StoneX Q3 2025 presentation: Revenue up 12%, completes strategic acquisitions

StoneX Group (SNEX) reported mixed fiscal Q3 2025 results, with operating revenues up 12% to $1.02 billion but diluted EPS slightly down 2% to $1.22, primarily due to a significant decline in its Commercial segment, though trailing twelve-month performance remained robust. Crucially, the firm announced the completion of two strategic acquisitions on July 31, 2025: R.J. O’Brien, establishing StoneX as the largest non-bank FCM in the US, and The Benchmark Company, expanding its institutional research and ECM capabilities. These acquisitions, funded by new debt and expected to enhance return on equity and drive future growth, position StoneX for strategic expansion into institutional services despite the quarterly earnings softness, making their integration a key focus for investors.

Analysis

StoneX Group (SNEX) presented a mixed fiscal third quarter for 2025, characterized by strategic expansion overshadowing a slight decline in profitability. While operating revenues grew a robust 12% year-over-year to $1.02 billion, diluted EPS fell 2% to $1.22, and return on equity contracted to 13.1% from 15.7%. This performance divergence was driven by strong growth in the Institutional segment, where net operating revenue increased 27%, contrasted by a significant 24% revenue decline in the Commercial segment. Despite the quarterly softness, performance on a trailing-twelve-month basis remained strong, with EPS up 22%, and book value per share grew an impressive 19.5% to $40.36. The central development was the completion of two major acquisitions: R.J. O’Brien, which establishes StoneX as the largest non-bank futures commission merchant in the U.S. and is expected to be accretive to ROE, and The Benchmark Company, which significantly expands its equity capital markets and research capabilities. The firm’s positive sensitivity to interest rates, where a 100 basis point increase is estimated to add $0.54 to EPS, provides a potential tailwind in a rising rate environment.

Key Decisions for Investors

• Investors should prioritize monitoring the integration of the R.J. O'Brien and Benchmark acquisitions, focusing on synergy realization and their contribution to institutional revenue growth and return on equity in subsequent quarters.
• Given the significant weakness in the Commercial segment, which dragged down quarterly results, it is critical to watch for signs of stabilization or a turnaround in this unit, as its performance could offset future gains from the strategic acquisitions.
• The company's stated positive sensitivity to interest rates makes its earnings outlook highly dependent on the macroeconomic environment; positions should be evaluated in the context of forward expectations for central bank policy.
• Considering the 19.5% growth in book value per share alongside a minor quarterly EPS decline, investors should assess whether the current stock price, trading near its 52-week high, fully reflects the long-term strategic value of the recent M&A activity.